June 10 (Reuters) - GlobeImmune Inc (GBIM.O) :
* Announces evaluation of strategic alternatives and corporate restructuring
* Says in conjunction with this process, the board has authorized eliminating the majority of positions in its workforce
* Says the board has authorized eliminating the majority of positions in its workforce
* Says does not have a defined timeline for the strategic review process
* Eliminatiion of workforce positions not expected to impact ongoing clinical trials conducted by collaborators in oncology and hepatitis b
* Source text for Eikon
* Further company coverage (GBIM.O)